Date:3/4/2010

---- ---- ---- ---- Revenue $25.7 $25.4 $90.0 $112.5 Gross Profit $7.8 $2.1 $24.1 $14.8 Operating Expenses Compensation expense $4.7 $5.1 $22.3 $22.8 Other SG&A $4.8 $3.9 $17.5 $16.8 Executive severance $- $- $0.2 $1.2 Asset Impairment $- $- $- $- Facilities realignment $- $- $- $- -- -- -- -- Total Operating Expenses $9.5 $8.9 $40.0 $40.8 Operating Loss $(1.7) $(6.8) $(15.9) $(26.0) Other income, net $- $0.3 $0.2 $2.8 (Benefit) Provision for Income Taxes $(0.3) $- $0.2 $0.9 ----- -- ---- ---- Net Loss $(1.4) $(6.5) $(15.9) $(24.0) ===== ===== ====== ====== Diluted Loss Per Share $(0.10) $(0.46) $(1.12) $(1.69) ====== ======
'/>"/>

SOURCE PDI, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
Related medicine technology :

1. IRIDEX Reports Fourth Quarter and Full Year 2009 Financial Results
2. Osteotech Reports Fourth Quarter and Full Year 2009 Financial Results
3. Volcano Reports 44 Percent Increase in Fourth Quarter Revenues
4. China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2009 Financial Results
5. WorldHeart Reports 2009 Financial Results
6. Questcor Reports Solid Fourth Quarter Results
7. APC Group, Inc. Reports Multi-Year Deal with Medical Device Manufacturer
8. CRF Health Reports Record Growth and Earnings
9. GeoVax Labs, Inc. Reports Fourth Quarter and Year End 2009 Financial Results
10. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
11. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results